Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05242575 · ClinicalTrials.gov registry record · NA

The Influence of Immersive Virtual Field Trips on Academic Vocabulary

A NA study of Developmental Language Disorder and Language Disorders in Children, sponsored by Salus University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05242575 is a NA study of Developmental Language Disorder and Language Disorders in Children that has completed, run by Salus University. The registered enrollment target is 30 participants, below the 181-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05242575, a NA study of Developmental Language Disorder and Language Disorders in Children, has completed, sponsored by Salus University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate an immersive virtual field trip (iVFT) on topic specific academic vocabulary for students with developmental language disorder (DLD). DLD is the most common childhood learning disorder with a prevalence of 7.4%(1) and occurs in the absence of a known biomedical condition (e.g., hearing loss, autism, stroke, intellectual disability). DLD affects a person's academic and social function due to difficulty with using and understanding language.(2,3) Approximately half of students with DLD have a deficit in vocabulary that persists through highschool.(4) Once children fall behind in their language and vocabulary development, it is very difficult to catch up generally resulting in a wider gap as they progress through their school years. This deficit can have cascading social, mental health, occupational and financial consequences.(5) There is preliminary evidence that a virtual reality experience such as an immersive virtual field trip (iVFT) was beneficial for facilitating vocabulary and comprehension in general education(6-8) and within targeted populations of students including second language learners(9) and those with learning differences (e.g., autism,(10) attention deficit hyperactivity,(11,12) and dyslexia(13). The term "immersive" refers to a state of heightened sensation when viewing a simulated environment that is superimposed onto a screen with embedded multisensory input (e.g., visual, auditory, proprioceptive).(14) The viewer looks through 3D goggles to block out the present environment resulting in a feeling of presence. These simulated experiences or destinations (e.g., space) are a type of VR referred to as an immersive virtual field trip (iVFT). To date, there is a lack of empirical evidence, explicitly targeting academic vocabulary growth for early grade school students with DLD. In addition, no study has reported on learning outcomes of students with DLD following a VR condition. Therefore, the primary study

Interventions

  • BEHAVIORAL The information provided in the iVFT and control book parallel one another.

Study Locations (1)

Pennsylvania

  • Salus University - Elkins Park

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-10-07
Est. Completion 2022-06-06
Phase NA

Sponsor

Salus University

7 total trials

What the Registry Record Tells You About NCT05242575

The ClinicalTrials.gov registry entry for NCT05242575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 181-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (83% lower). The listed sponsor is Salus University, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 1 intervention - of which The information provided in the iVFT and control book parallel one another. is the first listed.

NCT05242575 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05242575 about?

NCT05242575 is a clinical study titled "The Influence of Immersive Virtual Field Trips on Academic Vocabulary". The purpose of this study is to investigate an immersive virtual field trip (iVFT) on topic specific academic vocabulary for students with developmental language disorder (DLD). DLD is the most common childhood learning disorder with a prevalence of 7.4%(1) and occurs in the absence of a known biome...

What is the current status of trial NCT05242575?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-10-07. Estimated completion is 2022-06-06.

What conditions does trial NCT05242575 study?

This clinical trial studies the following conditions: Developmental Language Disorder, Language Disorders in Children.

What interventions are being tested in trial NCT05242575?

The interventions under investigation include: The information provided in the iVFT and control book parallel one another. (BEHAVIORAL).

Who is sponsoring clinical trial NCT05242575?

This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05242575 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.